Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,460 | 165 | 98.8% |
| Education | $52.00 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ANI Pharmaceuticals, Inc. | $390.76 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $355.44 | 12 | $0 (2024) |
| ABBVIE INC. | $316.61 | 15 | $0 (2024) |
| ARGENX US, INC. | $281.63 | 11 | $0 (2024) |
| Lilly USA, LLC | $239.53 | 11 | $0 (2024) |
| Lundbeck LLC | $226.04 | 12 | $0 (2024) |
| Horizon Therapeutics plc | $201.08 | 3 | $0 (2023) |
| EMD Serono, Inc. | $193.04 | 5 | $0 (2024) |
| Eisai Inc. | $189.43 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $187.67 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,592 | 93 | ANI Pharmaceuticals, Inc. ($367.63) |
| 2023 | $1,506 | 61 | Horizon Therapeutics plc ($152.78) |
| 2022 | $414.35 | 13 | Alexion Pharmaceuticals, Inc. ($110.62) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Neurology | ||||||
| 12/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Neurology | ||||||
| 12/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Rare Disease | ||||||
| 11/25/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: EPILEPSY | ||||||
| 11/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.45 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.44 | General |
| 11/12/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Neurology | ||||||
| 11/03/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/31/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Immunology and Neurology | ||||||
| 10/23/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Neuroscience | ||||||
| 10/18/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $367.63 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $2.00 | General |
| Category: Rare Disease | ||||||
| 10/16/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Neurology | ||||||
| 10/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: Neurology | ||||||
| 10/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 595 | 709 | $268,828 | $77,027 |
| 2022 | 4 | 77 | 107 | $26,592 | $8,073 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 112 | 112 | $62,608 | $18,067 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 98 | 126 | $57,204 | $16,566 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 122 | $39,040 | $11,324 | 29.0% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 38 | 38 | $27,588 | $8,018 | 29.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 78 | 104 | $25,896 | $7,488 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $25,803 | $6,746 | 26.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 32 | 32 | $17,216 | $4,918 | 28.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 56 | 74 | $6,216 | $1,720 | 27.7% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 24 | 27 | $4,293 | $1,266 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $2,964 | $914.55 | 30.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 24 | 24 | $13,416 | $4,063 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,653 | $1,456 | 31.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 29 | 57 | $4,788 | $1,385 | 28.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 13 | 15 | $3,735 | $1,168 | 31.3% |
About Dr. Michael Todinca, M.D
Dr. Michael Todinca, M.D is a Neurology healthcare provider based in Jacksonville Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2017. The National Provider Identifier (NPI) number assigned to this provider is 1770016800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Todinca, M.D has received a total of $4,512 in payments from pharmaceutical and medical device companies, with $2,592 received in 2024. These payments were reported across 167 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,460).
As a Medicare-enrolled provider, Todinca has provided services to 672 Medicare beneficiaries, totaling 816 services with total Medicare billing of $85,100. Data is available for 2 years (2022–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neuromuscular Medicine
- Location Jacksonville Beach, FL
- Active Since 04/05/2017
- Last Updated 10/05/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1770016800
Products in Payments
- PURIFIED CORTROPHIN GEL (Drug) $390.76
- UPLIZNA (Drug) $201.08
- ULTOMIRIS (Biological) $189.59
- VYVGART HYTRULO (Drug) $189.15
- KESIMPTA (Drug) $187.67
- UBRELVY (Drug) $185.22
- VYEPTI (Biological) $170.56
- Leqembi (Drug) $167.42
- BOTOX (Biological) $116.10
- Ocrevus (Biological) $115.57
- EMGALITY (Drug) $108.51
- AMYVID (Drug) $102.07
- HYQVIA (Biological) $99.00
- AJOVY (Biological) $85.76
- SKYCLARYS (Drug) $78.36
- Nourianz (Drug) $76.56
- NUEDEXTA (Drug) $76.43
- REXULTI (Drug) $74.69
- WAINUA (Drug) $71.00
- TYSABRI (Biological) $69.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Jacksonville Beach
Thomas Snyder, Md, MD
Neurology — Payments: $340,171
Dr. Robert Mannel, M.d, M.D
Neurology — Payments: $52,844
Dr. Christine Pierre, Md, MD
Neurology — Payments: $11,122
Dr. Michelle Nunes Caravaglio, Md, MD
Neurology — Payments: $2,734
Richard Boehme, Md, MD
Neurology — Payments: $2,084
Dr. Karen Thalinger, Md, MD
Neurology — Payments: $950.12